These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 2649898
21. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Dropcho EJ. Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221 [Abstract] [Full Text] [Related]
22. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S. J Neurol Sci; 1998 Nov 26; 161(1):88-90. PubMed ID: 9879687 [Abstract] [Full Text] [Related]
27. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration]. Miyatake T. Rinsho Shinkeigaku; 1993 Dec 26; 33(12):1291-3. PubMed ID: 8174327 [Abstract] [Full Text] [Related]
28. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG. PLoS One; 2015 Dec 26; 10(4):e0123446. PubMed ID: 25885452 [Abstract] [Full Text] [Related]
29. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration. Hida C, Tsukamoto T, Awano H, Yamamoto T. Arch Neurol; 1994 Jun 26; 51(6):555-8. PubMed ID: 8198465 [Abstract] [Full Text] [Related]
31. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Graus F, Segurado OG, Tolosa E. Acta Neurol Scand; 1988 Sep 26; 78(3):210-3. PubMed ID: 3227806 [Abstract] [Full Text] [Related]
32. Antibody to a zinc finger protein in a patient with paraneoplastic cerebellar degeneration. Sato S, Inuzuka T, Nakano R, Fujita N, Matsubara N, Sakimura K, Mishina M, Miyatake T. Biochem Biophys Res Commun; 1991 Jul 15; 178(1):198-206. PubMed ID: 1712585 [Abstract] [Full Text] [Related]
33. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration. Tanaka K, Tanaka M, Igarashi S, Onodera O, Nakajima T, Yamazaki M, Miyatake T, Tsuji S. J Neurol Neurosurg Psychiatry; 1995 Feb 15; 58(2):256-7. PubMed ID: 7876871 [No Abstract] [Full Text] [Related]
36. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR. Ann Neurol; 1999 Jun 15; 45(6):805-9. PubMed ID: 10360776 [Abstract] [Full Text] [Related]
37. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma]. Holzmann P, Holy D, Stillhard G, Janda M, Möbr P. Schweiz Med Wochenschr; 1998 Jun 06; 128(23):906-8. PubMed ID: 9658519 [Abstract] [Full Text] [Related]
38. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells. Schwenkenbecher P, Chacko L, Pul R, Sühs KW, Wegner F, Wurster U, Stangel M, Skripuletz T. Int J Neurosci; 2018 Aug 06; 128(8):721-728. PubMed ID: 29199513 [Abstract] [Full Text] [Related]